Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Financial Flexibility Index
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Financial Flexibility Index of 0.76x as of December 2024. Free cash flow of CN¥152.38 Million (operating CF CN¥47.07 Million minus capex CN¥105.31 Million) represents 1% of total liabilities (CN¥200.84 Million). Check 301258 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Suzhou Fushilai Pharmaceutical Co. Ltd. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. See working capital position of Suzhou Fushilai Pharmaceutical Co. Ltd. to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year free cash flow to debt coverage for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full company profile including market capitalisation, see market value of Suzhou Fushilai Pharmaceutical Co. Ltd..
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.76x | CN¥152.38 Million | CN¥47.07 Million | CN¥200.84 Million | ▼ -5.2% |
| 2023 | 0.80x | CN¥136.39 Million | CN¥94.77 Million | CN¥170.45 Million | ▼ -15.8% |
| 2022 | 0.95x | CN¥201.30 Million | CN¥151.19 Million | CN¥211.75 Million | ▼ -22.9% |
| 2021 | 1.23x | CN¥280.48 Million | CN¥199.73 Million | CN¥227.47 Million | ▼ -12.2% |
| 2020 | 1.40x | CN¥232.54 Million | CN¥166.85 Million | CN¥165.61 Million | ▲ +7.4% |
| 2019 | 1.31x | CN¥221.48 Million | CN¥150.55 Million | CN¥169.48 Million | — |